3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
8
Withdrawn
2
Unknown
2
Recruiting
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Motor Activity
8
Breast Neoplasms
4
Prostatic Neoplasms
3
Neoplasms
2
Colonic Neoplasms
2
Vomiting
1
Sedentary Behavior
1
Rectal Neoplasms
1
Prostatectomy
1
Obesity
1
Nausea
1
Lymphedema
1
Lung Neoplasms
1
Leukemia
1
Gastric Adenocarcinoma
1
Fatigue
1
Cardiometabolic Dysregulation
1
Brain Neoplasms
1
Atherosclerosis
1
Interventions
Fluorouracil
11
Leucovorin
10
Oxaliplatin
9
Bevacizumab
6
Irinotecan
5
Capecitabine
3
regorafenib
2
aflibercept
2
Folfox protocol
2
Exercise
2
Chemotherapy, Adjuvant
2
Cetuximab
2
Biopsy
2
Atorvastatin
2
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
sulindac sulfone
1
sargramostim
1
retrovector encoding mutant anti-cyclin G1
1
poly ICLC
1
pidilizumab
1
pembrolizumab
1
p53 peptide 264-272, human
1
nilotinib
1
monalizumab
1
lonafarnib
1
irofulven
1
infigratinib
1
grp protein, Drosophila
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Colonic Neoplasms
×
Exercise
×
Clear all
NCT04488159
2024-09-20
iMAGINE
Medical University of Vienna
Phase 3
Withdrawn
NCT01882972
2015-04-15
Strength for Health
Loyola University
Phase NA
Withdrawn